Protagonist Therapeutics Reports Granting of Inducement Awards
Protagonist Therapeutics granted inducement awards to three new employees, consisting of options to purchase 8,650 shares and restricted stock units for 2,275 shares. The options have an exercise price of $122.58, equal to the closing price on June 30, 2026, and vest over a four-year period.
Key figures
- Rsus granted
- 2275
- Exercise price
- 122.58
- Options granted
- 8650
- Vesting period years
- 4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.